SCHEMBL13639467

SCHEMBL13639467

NS(=O)(=O)c1cc(CO)ccc1NS(=O)(=O)CCc1ccc(C2CCCC2)cc1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784165 0.84 PTGES2 (1.00) PTGES2
SCHEMBL3782521 0.83 PTGES2 (1.00) PTGES2
SCHEMBL3783846 0.82 PTGES2 (1.00) PTGES2
SCHEMBL3771869 0.82 PTGES2 (0.78) PTGES2
SCHEMBL13061981 0.80 PTGES2 (0.74) PTGES2
SCHEMBL3777265 0.75 PTGES2 (1.00) PTGES2
SCHEMBL3782523 0.72 PTGES2 (0.54) PTGES2
SCHEMBL3771805 0.70 PTGES2 (0.78) PTGES2
SCHEMBL3782656 0.69 PTGES2 (1.00) PTGES2
SCHEMBL3777997 0.69 PTGES2 (1.00) PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234993-B1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2012-11-07 EP disclosed
WO-2009082347-A1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2009-07-02 WO disclosed